Antimicrobial resistance in Klebsiella pneumoniae: an overview of common mechanisms and a current Canadian perspective

Can J Microbiol. 2024 Dec 1;70(12):507-528. doi: 10.1139/cjm-2024-0032. Epub 2024 Aug 30.

Abstract

Klebsiella pneumoniae is a ubiquitous opportunistic pathogen of the family Enterobacteriaceae. K. pneumoniae is a member of the ESKAPEE pathogens (Enterococcus faecium, Staphylococcus aureus, K. pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli), a group of bacteria that cause nosocomial infections and are able to resist killing by commonly relied upon antimicrobial agents. The acquisition of antimicrobial resistance (AMR) genes is increasing among community and clinical isolates of K. pneumoniae, making K. pneumoniae a rising threat to human health. In addition to the increase in AMR, K. pneumoniae is also thought to disseminate AMR genes to other bacterial species. In this review, the known mechanisms of K. pneumoniae AMR will be described and the current state of AMR K. pneumoniae within Canada will be discussed, including the impact of the coronavirus disease-2019 pandemic, current perspectives, and outlook for the future.

Keywords: Klebsiella pneumoniae; One Health; antibiotic resistance; antimicrobial resistance; biofilm.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • COVID-19 / microbiology
  • Canada
  • Cross Infection / microbiology
  • Drug Resistance, Bacterial*
  • Humans
  • Klebsiella Infections* / drug therapy
  • Klebsiella Infections* / epidemiology
  • Klebsiella Infections* / microbiology
  • Klebsiella pneumoniae* / drug effects
  • Klebsiella pneumoniae* / genetics
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / genetics

Substances

  • Anti-Bacterial Agents